306 related articles for article (PubMed ID: 31689591)
21. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
Negi M; Dixit T; Venkatesh V
Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
[TBL] [Abstract][Full Text] [Related]
22. Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity.
Xie K; Lu XY; Zhu H; Zhu LY; Li RT; Ye RR
Dalton Trans; 2024 May; 53(20):8772-8780. PubMed ID: 38712840
[TBL] [Abstract][Full Text] [Related]
23. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria.
Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D
J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986
[TBL] [Abstract][Full Text] [Related]
25. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis, and Anticancer Effect Studies of Iridium(III) Polypyridyl Complexes against SGC-7901 Cells.
Zhang LX; Gu YY; Wang YJ; Bai L; Du F; Zhang WY; He M; Liu YJ; Chen YZ
Molecules; 2019 Aug; 24(17):. PubMed ID: 31466318
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
28. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
[TBL] [Abstract][Full Text] [Related]
29. Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.
Li W; Shi C; Wu X; Zhang Y; Liu H; Wang X; Huang C; Liang L; Liu Y
J Inorg Biochem; 2022 Nov; 236():111977. PubMed ID: 36030672
[TBL] [Abstract][Full Text] [Related]
30. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
[TBL] [Abstract][Full Text] [Related]
31. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
[TBL] [Abstract][Full Text] [Related]
32. New iridium bis-terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials.
Sahin C; Mutlu D; Nasirli F; Mahmoudi G; Zubkov FI; Arslan S; Dogan NM
Biometals; 2021 Jun; 34(3):701-713. PubMed ID: 33900533
[TBL] [Abstract][Full Text] [Related]
33. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
34. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
35. Anticancer Ir
Wu XW; Zheng Y; Wang FX; Cao JJ; Zhang H; Zhang DY; Tan CP; Ji LN; Mao ZW
Chemistry; 2019 May; 25(28):7012-7022. PubMed ID: 30913329
[TBL] [Abstract][Full Text] [Related]
36. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
Li Y; Wang KN; He L; Ji LN; Mao ZW
J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.
Xie B; Wang Y; Wang D; Xue X; Nie Y
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080200
[TBL] [Abstract][Full Text] [Related]
39. Influence of substituents on DNA and protein binding of cyclometalated Ir(iii) complexes and anticancer activity.
Mukhopadhyay S; Singh RS; Paitandi RP; Sharma G; Koch B; Pandey DS
Dalton Trans; 2017 Jul; 46(26):8572-8585. PubMed ID: 28640302
[TBL] [Abstract][Full Text] [Related]
40. Photoactivatable, mitochondria targeting dppz iridium(III) complex selectively interacts and damages mitochondrial DNA in cancer cells.
Kasparkova J; Novohradsky V; Ruiz J; Brabec V
Chem Biol Interact; 2024 Apr; 392():110921. PubMed ID: 38382705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
